BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 10/12/2025

FDA Issues Final Guidance on Promotional Labeling and Advertising for Prescription Biological Products

The FDA has released a final guidance document addressing promotional labeling and advertising considerations for prescription biological products, biosimilar products, and interchangeable biosimilar products, providing clarity for manufacturers and industry firms.

Source: Federal Register — Food and Drug AdministrationOpen original release →